Clinuvel Pharmaceuticals Ltd. revenue for the last year amounted to 53.03 M USD, the most of which — 52.68 M USD — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 47.66 M USD. The greatest contribution to the revenue figure was made by Europe & United States — last year it brought Clinuvel Pharmaceuticals Ltd. 48.62 M USD, and the year before that — 43.61 M USD.